Transcription of QOLに関するPatient Reported Outcomeの評価
1 QOL Patient Reported Outcome 1 Quality of Life QOL QOL QOL [1,2] 2 QOL QOL QOL QOL QOL QOL QOL [3-5] 3 QOL QOL [3-6] QOL QOL QOL QOL QOL [1,5] 4 QOL QOL 1990 European Organization for Research and Treatment of cancer EORTC core questionnaire QLQ-C30 [6] Func-tional Assessment of cancer Therapy Scale-General FACT-G [7]
2 EORTC QLQ-C30 FACT-G [8,9] EORTC QLQ-C30 FACT-G EORTC QLQ-C30 30 QOL FACT-G 27 EORTC FACT EORTC [ ] FACT [ ] MSS-4 12 QOL 463 JSCO 49 2 EORTC QLQ-LC13 [10] FACT-L[11] EORTC QLQ-STO22[12] FACT-Ga[13] 5 QOL QOL 1 QOL 1 3 6 1 clinical research coordinator CRC CRC QOL CRC
3 QOL [14-16] 6 1 Levine MN, Ganz PA. Beyond the development of quality-of-life instruments: where do we go from here? J Clin Oncol 2002; 20 Morris J, Perez D, McNoe B. The use of quality of life data in clinical practice. Qual Life Res 1998; 7 Aaronson NK, Bullinger M, Ahmedzai S. A modu-lar approach to quality-of-life assessment in cancer clinical trials. Recent Results cancer Res 1988; 111 Moinpour CM, Feigl P, Metch B, et al. Quality of life end points in cancer clinical trials: Reviews and recommendations. J Natl cancer Inst 1989; 81:485-495. 5 Testa MA, Simonson DC. Assessment of quality-of-life outcomes.
4 N Engl J Med 1996; 334 Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treat-ment of cancer QLQ-C30: A quality-of-life instru-ment for use in international clinical trials in oncol-ogy. J Natl cancer Inst 1993; 85 Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993; 11 Kobayashi K, Takeda F, Teramukai S, et al. A cross-validation of the European Organization for Research and Treatment of cancer QLQ-C30 EORTC QLQ-C30 for japanese with lung cancer [see comments]. Eur J cancer 1998; 34 Fumimoto H, Kobayashi K, Chang CH, et al.
5 Cross-cultural validation of an international questionnaire, the general measure of the Functional Assessment of cancer Therapy FACT-G , for japanese . Qual Life Res 2001; 10 Bergman B, Aaronson NK, Ahmedzai S, et al. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire QLQ-C30 for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur J cancer 1994; 30 Cella DF, Bonomi AE, Lloyd SR, et al. Reliability and validity of the Functional Assessment of Can-cer Therapy-Lung FACT-L quality of life instru-ment. Lung cancer 1995; 12 Morita S, Kaptein AA, Oba K, Sakamoto J. The Domain Structure of the EORTC QLQ-STO22 Sup-ported by japanese Validation Data.
6 Psycho-Oncol-ogy 17: 474-9, Eremenco SL, Cashy J, Webster K, Ohashi Y, Lock-er GY, Pelletier G, and Cella D. FACT- gastric : A new international measure of QOL in gastric can-cer. J Clin Oncol 2004; 22: 8123. 14 , , . QOL . , M . QOL . , . : . , 49 2
